Vitiligo: A Comprehensive Review of the Etiology, Pathogenesis and Therapeutic Approaches to a Complex Dermatological Disease of Cutaneous Depigmentation
Main Article Content
Abstract
Vitiligo, an enigmatic and complex skin disease, is notable for the appearance of depigmented patches that arise due to the selective and progressive loss of melanocytes, the cells responsible for melanin production. This autoimmune pathology affects individuals of both genders and has been the subject of historical interest due to its unusual clinical presentation and its impact on patients' quality of life. The etiology of vitiligo is multifactorial, involving a combination of genetic, environmental and autoimmune factors leading to melanocyte destruction.
Although diagnosis is usually based on visual examination of the skin lesions, additional tests may be required to rule out other conditions with similar features. Although a definitive cure has not yet been found, a variety of therapeutic approaches, including topical treatments, phototherapy, systemic therapy and surgical options, are available to attempt to repigment affected areas and improve patients' quality of life. Continued research and a deeper understanding of the pathogenesis of vitiligo are essential to address this disease more effectively and provide more successful therapeutic solutions.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, Pasquariello B, Magliulo G. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews. 2016 04;15(4):335-343. https://doi.org/10.1016/j.autrev.2015.12.006
II. Xie, H. et al. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci. 2015; https://doi.org/10.1016/j.jdermsci.2015.09.003.
III. Speeckaert, R. et al. Vitiligo: An Update on Pathophysiology and Treatment Options. Am J Clin Dermatol. 2017; 18: 733-744. https://doi.org/10.1007/s40257-017-0298-5
IV. Rashighi, M. et al. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017; 35 (2): 257-265. https://doi.org/10.1016/j.det.2016.11.014
V. Mole, M. and Coringrato, M. Update on vitiligo. Dermatología Argentina. 2019; 25 (2): 50-57. Available: http://www.dermatolarg.org.ar/index.php/dermatolarg/article/viewArticle/1874
VI. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. Journal of the American Academy of Dermatology. 2011 09;65(3):473-491. https://doi.org/10.1016/j.jaad.2010.11.061
VII. Rodrigues, M. et al. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017; 77:1-13. http://dx.doi.org/10.1016/j.jaad.2016.10.048
VIII. Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nature Reviews DiseasePrimers. 2015 06 04;1(1). https://doi.org/10.1038/nrdp.2015.11.
IX. Boniface, K. et al. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clinic Rev Allerg Immunol. (2018); 54:52-67. https://doi.org/10.1007/s12016-017-8622-7
X. Goh B, Pandya AG. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo. Dermatologic Clinics. 2017 04;35(2):135-144. https://doi.org/10.1016/j.det.2016.11.004
XI. Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review. International Journal of Dermatology. 2018 05 28;57(10):1157-1164. https://doi.org/10.1111/ijd.14055
XII. Blanca Lucina Campos-Cabrera, Juan Carlos Juárez-Echenique, Marimar Saez-de Ocariz, Luz Orozco-Covarrubias. Association between vitiligo and ophthalmologic alterations. Dermatol Rev Mex. 2019; 63 (3): 268-277. Available at:https://www.medigraphic.com/pdfs/derrevmex/rmd-2019/rmd193d.pdf
XIII. Elbuluk N, Ezzedine K. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatologic Clinics. 2017 04;35(2):117-128. https://doi.org/10.1016/j.det.2016.11.002
XIV. Passeron T. Medical and Maintenance Treatments for Vitiligo. Dermatologic Clinics. 2017 04;35(2):163-170. https://doi.org/10.1016/j.det.2016.11.007
XV. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. The Lancet. 2015 07;386(9988):74-84. https://doi.org/10.1016/s0140-6736(14)60763-7
XVI. Hönigsmann, H. and Schwarz, H. Ultraviolet light treatment, Physical treatment modalities. 2019; 2325-2341